GOLM1 and fibrosis: However, both GP73 and LG2m median concentrations in the validation cohort were slightly higher for patients with fibrosis (GP73 115.10 ng/mL; LG2m 42.30 pg/mL) compared to patients with cirrhosis (GP73 91.11 ng/mL; LG2m 22.65 pg/mL; Fig. 1C, D).